- Home
- HTFL vs CLVT Comparison
HTFL vs CLVT Comparison
Compare HTFL & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTFL | CLVT |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | HTFL | CLVT |
|---|---|---|
| Price | $29.82 | $3.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $39.50 | $4.50 |
| AVG Volume (30 Days) | 751.8K | ★ 5.5M |
| Earning Date | 02-08-2026 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $161,881,000.00 | ★ $2,501,200,000.00 |
| Revenue This Year | $40.42 | N/A |
| Revenue Next Year | $22.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 85.70 | N/A |
| 52 Week Low | $25.38 | $3.04 |
| 52 Week High | $41.22 | $5.74 |
Technical Indicators
Market Signals| Indicator | HTFL | CLVT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 50.03 |
| Support Level | N/A | $3.28 |
| Resistance Level | N/A | $3.59 |
| Average True Range (ATR) | 0.00 | 0.18 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 53.26 |
Price Performance
Historical ComparisonAbout HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.